Pelin Cinar, MD

Gastrointestinal cancer specialist

Dr. Pelin Cinar is a specialist in gastrointestinal oncology with an interest in pancreatic cancer. As the director of quality improvement for the UCSF Helen Diller Family Comprehensive Cancer Center, she is committed to developing projects to ensure each oncology patient at UCSF receives high-quality care.

Cinar earned her medical degree and completed her residency in internal medicine at the UC Irvine School of Medicine. She received her hematology and oncology fellowship training at UC San Francisco, where she was appointed as the chief fellow. During her fellowship, she developed an interest in quality improvement in health care and participated in quality improvement efforts within the Division of Oncology.

In 2014, she joined the Stanford Department of Medicine faculty in the Division of Oncology as a gastrointestinal oncologist. She also held the position of assistant medical director for cancer care quality and the associate director for quality and curriculum for the oncology fellowship program. She was selected to participate in the American Society of Clinical Oncology Quality Training Program in 2015.

Clinics

Gastrointestinal Medical Oncology Clinic
1825 Fourth St., Fourth Floor
San Francisco, CA 94158
Phone: (415) 353-9888
Fax: (415) 353-9931

Hours: Monday to Friday
8 a.m. – 5 p.m.

Board Certification

Internal Medicine
Medical Oncology

More about Pelin Cinar

Additional Languages

Armenian
Turkish

Education

UC Irvine School of Medicine 2007

Residencies

UC Irvine Medical Center 2010

Fellowships

UCSF Medical Center 2013

Selected Research and Publications

  1. Cinar P, Ko AH. Best practices for the treatment of metastatic pancreatic adenocarcinoma: the therapeutic landscape in 2017. Chin Clin Oncol. 2017 Jun; 6(3):29.
  2. Cinar P, Calkins SM, Venook AP, Kelley RK. A case series of patients with HER2-overexpressed primary metastatic gastroesophageal adenocarcinoma. Anticancer Res. 2014 Dec; 34(12):7357-60.
  3. Cinar P, Ko AH. Evolving treatment options for locally advanced unresectable pancreatic ductal adenocarcinoma. J Natl Compr Canc Netw. 2014 Feb; 12(2):167-72.
  4. Cinar P, Tempero MA. Monoclonal antibodies and other targeted therapies for pancreatic cancer. Cancer J. 2012 Nov-Dec; 18(6):653-64.
  5. Zell JA, Cinar P, Mobasher M, Ziogas A, Meyskens FL, Anton-Culver H. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol. 2008 Jan 01; 26(1):66-75.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.